IMARA (IMRA) CFO Hohl sold 11,870 shares for $178K at an average $15.02 under a 10b5-1 plan
Insider transactions reported
Benjamin Hohl (Chief Financial Officer at IMARA Inc., IMRA) reported that they sold 11,870 shares for $178K at an average $15.02, and acquired 11,870 shares at $2.48 between Dec 28, 2023 and Jan 2, 2024. After these transactions the filing shows 0 shares held directly.
- Reporting person
- Hohl Benjamin
- Role
- Chief Financial Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 28, 2023 | Exercise or conversion of a derivative (M) | Common Stock1 | +2,467 | $2.48 | $6,118 | 2,467 direct |
| Dec 28, 2023 | Open-market sale (S) | Common Stock1, 2 | -2,467 | $15.07 | $37.2K | 0 direct |
| Dec 29, 2023 | Exercise or conversion of a derivative (M) | Common Stock1 | +20 | $2.48 | $49.60 | 20 direct |
| Dec 29, 2023 | Open-market sale (S) | Common Stock1 | -20 | $15.00 | $300 | 0 direct |
| Jan 2, 2024 | Exercise or conversion of a derivative (M) | Common Stock1 | +9,383 | $2.48 | $23.3K | 9,383 direct |
| Jan 2, 2024 | Open-market sale (S) | Common Stock1, 3 | -9,383 | $15.01 | $141K | 0 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 28, 2023 | Exercise or conversion of a derivative (M) | Employee Stock Option (right to buy)On 2,467 Common Stock1, 4 | -2,467 | - | - | 258,523 direct |
| Dec 29, 2023 | Exercise or conversion of a derivative (M) | Employee Stock Option (right to buy)On 20 Common Stock1, 4 | -20 | - | - | 258,503 direct |
| Jan 2, 2024 | Exercise or conversion of a derivative (M) | Employee Stock Option (right to buy)On 9,383 Common Stock1, 4 | -9,383 | - | - | 249,120 direct |
Holdings before and after
- Employee Stock Option (right to buy): 260,990 to 249,120 direct
Footnotes from the filing
- 1. The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.
- 2. This transaction was executed in multiple trades at prices ranging from $15.00 to $15.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- 4. The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Hohl report in this IMRA Form 4?
Benjamin Hohl (Chief Financial Officer at IMARA Inc., IMRA) reported that they sold 11,870 shares for $178K at an average $15.02, and acquired 11,870 shares at $2.48 between Dec 28, 2023 and Jan 2, 2024. After these transactions the filing shows 0 shares held directly.
How many IMRA shares does Hohl hold after this filing?
The filing shows 0 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this IMRA insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for IMRA
Earlier insider filings at IMRA
- Dec 28, 2023Kintz Samuel exercised 12,000 shares at a strike of $1.12 and sold $175,709 worth of shares (12,000 units at $14.64) (SEC Form 4)
- Dec 27, 2023Patel Anish sold $16,306 worth of shares (1,085 units at $15.03), decreasing direct ownership by 3% to 35,637 units (SEC Form 4)
- Dec 27, 2023Hohl Benjamin exercised 1,130 shares at a strike of $2.48 and sold $17,025 worth of shares (1,130 units at $15.07) (SEC Form 4)
- Dec 27, 2023Lyssikatos Joseph P exercised 6,566 shares at a strike of $1.12 and sold $85,790 worth of shares (6,566 units at $13.07) (SEC Form 4)
- Dec 27, 2023Kintz Samuel exercised 8,195 shares at a strike of $1.12 and sold $106,915 worth of shares (8,195 units at $13.05) (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2020
Follow IMRA and get a push notification the moment its next story breaks.